Uptake Difference by Somatostatin Receptors in a Patient with Neuroendocrine Tumor: 99mTc-Octreotide Uptake in the Lung without Uptake in Liver Lesions

about

Uptake Difference by Somatostatin Receptors in a Patient with Neuroendocrine Tumor: 99mTc-Octreotide Uptake in the Lung without Uptake in Liver Lesions

Item

http://www.wikidata.org/entity/Q36556526

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Uptake Difference by Somatosta ...... ithout Uptake in Liver Lesions

@ast

Uptake Difference by Somatosta ...... ithout Uptake in Liver Lesions

@en

type

Item

label

Uptake Difference by Somatosta ...... ithout Uptake in Liver Lesions

@ast

Uptake Difference by Somatosta ...... ithout Uptake in Liver Lesions

@en

prefLabel

Uptake Difference by Somatosta ...... ithout Uptake in Liver Lesions

@ast

Uptake Difference by Somatosta ...... ithout Uptake in Liver Lesions

@en

P1476

Uptake Difference by Somatosta ...... ithout Uptake in Liver Lesions

@en

P2093

Elahe Pirayesh

http://www.w3.org/2001/XMLSchema#string

Mahasti Amoui

http://www.w3.org/2001/XMLSchema#string

Majid Assadi

http://www.w3.org/2001/XMLSchema#string

P2860

Expression of somatostatin receptor types 1-5 in 81 cases of gastrointestinal and pancreatic endocrine tumors. A correlative immunohistochemical and reverse-transcriptase polymerase chain reaction analysis

Imaging of neuroendocrine tumors

Changing paradigms with molecular imaging of neuroendocrine tumors

The presence of somatostatin receptors in malignant neuroendocrine tumor tissue predicts responsiveness to octreotide.

Successful application of technetium-99m-labeled octreotide acetate scintigraphy in the detection of ectopic adrenocorticotropin-producing bronchial carcinoid lung tumor: a case report.

Tumor heterogeneity: mechanisms and bases for a reliable application of molecular marker design

In vitro and in vivo detection of somatostatin receptors in human malignant tissues.

Nuclear medicine techniques for the imaging and treatment of neuroendocrine tumours.

Effect of tumor heterogeneity on the assessment of Ki67 labeling index in well-differentiated neuroendocrine tumors metastatic to the liver: implications for prognostic stratification.

Radioiodinated metaiodobenzylguanidine: a review of its biodistribution and pharmacokinetics, drug interactions, cytotoxicity and dosimetry.

P304

128-131

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.4274/MIRT.02996

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

283806162

http://www.w3.org/2001/XMLSchema#string

P698

27529888

http://www.w3.org/2001/XMLSchema#string

P932

4745405

http://www.w3.org/2001/XMLSchema#string